White label ELPA - ClinicalTrials.eu

Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

Recruiting

2 1 1 1
Investigated diseases:
- Rectal cancer
Investigated drugs:
- Dostarlimab
Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Recruiting

4 1 1 1
Investigated diseases:
- Triple negative breast cancer
- Breast cancer
Investigated drugs:
+4
Study of Trastuzumab Deruxtecan Blood Levels in Normal Weight and Overweight Patients with Metastatic Breast Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:
- Trastuzumab Deruxtecan
Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

Recruiting

3 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- IMEROPRUBART
+3
Study of HPV antibody response in urine samples before and after HPV 9-valent vaccine in people with Human Papillomavirus infection

Recruiting

2 1 1 1
Investigated diseases:
- Papilloma viral infection
Investigated drugs:
Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment

Recruiting

3 1 1
Investigated drugs:
- Rilzabrutinib
+2
Study of ciltacabtagene autoleucel in patients with newly diagnosed multiple myeloma using a modified treatment preparation regimen

Recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Ciltacabtagene Autoleucel
Study of budesonide, glycopyrronium and formoterol inhaler to evaluate heart and lung function in patients with chronic obstructive pulmonary disease and hyperinflation

Recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

Recruiting

3 1 1 1
Investigated diseases:
- Iron deficiency
Study of glucagon effects on physical capacity in patients with heart failure with preserved ejection fraction (HFpEF) with or without liver steatosis

Recruiting

2 1 1
Investigated drugs:
- Glucagon
- Human Plasma Protein

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies